Alzheimer's Disease

What is Alzheimer’s disease? Alzheimer’s disease is the most common form of dementia, usually accounting for 60 to 80 percent of all cases. This degenerative disease affects millions of people world wide. Alzheimer’s disease affects people in different ways, but early symptoms of the disease are usually manifested through an inability to remember new pieces of information, apathy, and/or depression. More advanced symptoms of the disease include impaired judgement, confusion, changes in behaviour and difficulties breathing, swallowing and walking. As the disease progresses, ‘plaques’ and ‘tangles’ develop in the brain which cause the death of brain cells. Individuals that suffer from Alzheimer’s disease have been found to have a shortage of chemicals in the brain that help with the transmission of messages.

For more information on Alzheimer’s disease visit and

How does Galanthamine work? Galanthamine works by inhibiting the breakdown of acetylcholine which is a neurotransmitter that carries messages between brain cells. Individuals that suffer from Alzheimer’s disease produce less acetylcholine as they age, Galanthamine reduces the rate at which acetylcholine is reduced and acts on the target brain cells to strengthen its response to available acetylcholine.

Click here for more detailed information on Galanthamine and Acetylcholinesterase Inhibitors (AChEls) (this document requires Adobe Reader)

How can Galanthamine help those who are suffering from Alzheimer’s disease? Although currently there is no cure for Alzheimer’s disease, there are medical treatments that include Galanthamine that can significantly improve the quality of life of those who suffer from the disease. Galanthamine can ameliorate the symptoms or slow down the progression of the disease in some individuals. Galanthamine can help to stabilize the disease for a limited time period.

NICE (National Institute for Health and Clinical Excellence) has recently reversed a previous decision for the use of Alzheimer’s drugs and now says that the many thousands of patients in the early stages of Alzheimer’s disease should receive drugs, like those which contain Galanthamine, to lessen their symptoms.

Click here for more information about Alzheimer’s disease and related information.